Non-clinical immunogenicity assessment of a new recombinant porcine sequence FVIII (OBI-1)

被引：0
|
作者：
Allacher, Peter [1 ]
Horling, Frank [1 ]
Piskernik, Christina [1 ]
Leidenmuehler, Peter [1 ]
Reipert, Birgit [1 ]
机构：
[1] Baxter BioSci, Vienna, Austria
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 43 条
  • [21] A phase II open-label study evaluating the hemostatic activity, pharmacokinetics and safety of recombinant porcine factor VIII (OBI-1) in hemophilia A patients with inhibitors directed against human FVIII
    Mahlangu, J.
    Andreeva, T.
    Macfarlane, D.
    Reding, M.
    Walsh, C.
    Ewing, N.
    Kessler, M.
    Kempton, C.
    Mathew, P.
    Plyushch, O.
    Shapiro, A.
    St-Louis, J.
    Warrier, I.
    Hoots, K.
    [J]. HAEMOPHILIA, 2008, 14 : 15 - 16
  • [22] A phase II open-label study evaluating hemostatic activity, pharmacokinetics and safety of recombinant porcine factor VIII (OBI-1) in hemophilia A patients with alloantibody inhibitors directed against human FVIII
    Mahlangu, Johnny
    Andreeva, Tatiana A.
    Macfarlane, Donald
    Reding, Mark T.
    Walsh, Christopher
    Ritchie, Bruce
    Ewing, Nadia
    Kessler, Craig M.
    Kempton, Christine
    Libby, Edward
    Zozulya, Nadezda
    Shapiro, Amy D.
    St-Louis, Jean
    Warrier, Indira
    Hoots, W. Keith
    Gruppo, Ralph A.
    Mueksch, Josef N.
    [J]. BLOOD, 2007, 110 (11) : 241A - 241A
  • [23] Efficacy and safety of B-domain deleted recombinant porcine factor VIII (OBI-1) in the treatment of acquired hemophilia A: interim results
    Greist, A.
    Shapiro, A.
    Kruse-Jarres, R.
    St Louis, J.
    Smith, H.
    Gomperts, E.
    [J]. HAEMOPHILIA, 2012, 18 : 1 - 1
  • [24] Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results
    St Louis, Jean
    Kruse-Jarres, Rebecca
    Greist, Anne
    Shapiro, Amy D.
    Smith, Hedy
    Drebes, Anja B.
    Lozier, Jay N.
    Gomperts, Edward D.
    [J]. BLOOD, 2012, 120 (21)
  • [25] Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone
    Lozier, J. N.
    Nghiem, K.
    Lee, M.
    Hodsdon, B.
    Joe, g.
    Weitzel, R. P.
    Tisdale, J. F.
    Hsieh, M.
    [J]. HAEMOPHILIA, 2014, 20 (02) : E185 - E188
  • [26] The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity
    Jankowski, Wojciech
    Kidchob, Christopher
    Bunce, Campbell
    Cloake, Edward
    Resende, Ricardo
    Sauna, Zuben E.
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] Non-clinical Safety Assessment of Angiotensin 1-7
    Thun, S.
    Petersen, K. U.
    Christoph, T.
    Schmitz, U.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S79 - S79
  • [28] Acquired Hemophilia A in an African-American Male After Stem Cell Transplant for Sickle Cell Disease: Successful Treatment with Recombinant Porcine Factor VIII (OBI-1) and Tolerance Induction with Rituximab and Prednisone
    Lozier, Jay N.
    Nghiem, Khanh
    Lee, Martin
    Hodsdon, Bonnie
    Joe, Galen
    Weitzel, R. Patrick
    Tisdale, John F.
    Hsieh, Matthew
    [J]. BLOOD, 2012, 120 (21)
  • [29] Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challenges
    Brennan, Frank R.
    Andrews, Laura
    Arulanandam, Antonio R.
    Blumel, Jorg
    Fikes, Jim
    Grimaldi, Christine
    Lansita, Janice
    Loberg, Lise I.
    MacLachlan, Tim
    Milton, Mark
    Parker, Suezanne
    Tibbitts, Jay
    Wolf, Jayanthi
    Allamneni, Krishna P.
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2018, 98 : 98 - 107
  • [30] Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates
    Xuefeng Zhang
    Jing Wang
    Jing Lu
    Rongrong Li
    Shuli Zhao
    [J]. Virology Journal, 15
12345